Peptide record

TPDB10211

Antibacterial Antifungal Antiparasitic Hemolysis Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10211
Antibacterial Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 APD_complete PD_Hemolysis ToxinPred 3.0
standard
No
A 23-aa standard-residue multi-activity (Antibacterial, Antifungal, Antiparasitic, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFLDVVKHIGKAALGAVTHLINQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C110H181N31O29
RCEMPSWY
AGLV
2401.84
9.88
4
1
12
+1
-0.18
0.635
135.65
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
3
A
0
R
1
N
1
D
0
C
0
E
1
Q
3
G
2
H
2
I
3
L
2
K
0
M
1
F
0
P
0
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 1 C: 0 E: 0 Q: 1 G: 3 H: 2 I: 2 L: 3 K: 2 M: 0 F: 1 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
23 reviewed residue count
C110H181N31O29 sequence-only estimate (linear, free termini)
2401.84 sequence-only estimate (linear, free termini)
9.88 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.18 sequence-only estimate (linear, free termini)
0.635 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E. coli (13.3 uM), S. aureus (13.3 uM), and C. albicans (13.3 uM). Updated 7/2021
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E. coli (13.3 uM), S. aureus (13.3 uM), and C. albicans (13.3 uM). Updated 7/2021
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli (13.3 uM), S. aureus (13.3 uM), and C. albicans (13.3 uM). Updated 7/2021
Evidence 4 Activity

Activity

1% Hemolysis
Toxicity
4-8 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 4-8 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 5 Activity

Activity

2% Hemolysis
Toxicity
16 µg/mL
Hemolytic Cytotoxic
2% Hemolysis | 16 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 6 Activity

Activity

6% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
6% Hemolysis | 32 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 7 Activity

Activity

24% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
24% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 8 Activity

Activity

59% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
59% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 9 Activity

Activity

83% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
83% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 10 Activity

Activity

96% Hemolysis
Toxicity
512 µg/mL
Hemolytic Cytotoxic
96% Hemolysis | 512 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 11 Activity

Activity

50% Cytotoxicity
Toxicity
127.19±0.3 µM
Cytotoxic
50% Cytotoxicity | 127.19±0.3 | µM | target cell: Bone marrow-derived macrophages (BMDMs)

Target

Bone marrow-derived macrophages (BMDMs)

Source & Reference

NA
DBAASP
Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents. | Pathog Dis | 2020
Evidence 12 Hemolysis

Source & Reference

APD_complete PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.